FDA Adverse Event Malfunction Summary report: N

ENDOTAK RELIANCE

MDR report key: 3050162 · Received April 10, 2013

Report

Report Number
2124215-2013-05516
Event Type
Malfunction
Date Received
April 10, 2013
Date of Event
February 18, 2013
Report Date
November 5, 2013
Manufacturer
CPI - DEL CARIBE
Product Code
NVY
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS CURRENTLY AVAILABLE, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

FURTHER INFORMATION WAS RECEIVED THAT ADDITIONAL OUT OF RANGE, SHOCK LEAD IMPEDANCE MEASUREMENTS WERE DETECTED. THE HEALTH CARE PROFESSIONAL (HCP) REPORTED THEY ARE AWARE OF THE ISSUE AND ARE MONITORING. AT THIS TIME, THE SYSTEM REMAINS IN SERVICE AND THERE HAVE BEEN NO ADVERSE PATIENT EFFECTS REPORTED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS PATIENT'S HOME MONITORING SYSTEM DETECTED A HIGH, OUT-OF-RANGE (OOR), SHOCK LEAD IMPEDANCE FOR THIS RIGHT VENTRICULAR (RV) LEAD AND CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D) SYSTEM. NO ADVERSE PATIENT EFFECTS WERE REPORTED. THE FIELD REPRESENTATIVE (REP) CONTACTED THE CLINIC AND WAS TOLD THAT PATIENT HAD BEEN SEEN IN THE CLINIC, BUT NO FURTHER INFORMATION WAS PROVIDED TO THE REP. AT THIS TIME, EVIDENCE SUGGESTS THAT THE SYSTEM REMAINS IN SERVICE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
149586 ENDOTAK RELIANCE NVY CPI - DEL CARIBE 0292

Patients

Seq Age Sex Outcome Treatment
1 65 YR E142| 0292| 4135| 5076| 7288| 6949